Clinical characteristics associated with BRAF, NRAS and KIT mutations in Japanese melanoma patientsKaori Sakaizawa, Hisashi Uhara, Naoya Yamazaki et al.|Journal of Dermatological Science|2015Cited by 120
Nectin Cell Adhesion Molecule 4 (NECTIN4) Expression in Cutaneous Squamous Cell Carcinoma: A New Therapeutic Target?Yuka Tanaka, Takamichi Ito|Biomedicines|2021Cited by 33
Systemic therapy for Asian patients with advanced <scp>BRAF V600</scp>‐mutant melanoma in a real‐world setting: A multi‐center retrospective study in Japan (<scp>B‐CHECK‐RWD</scp> study)Kenjiro Namikawa, Naoya Yamazaki, Takamichi Ito et al.|Cancer Medicine|2023Cited by 25
Immunohistochemical BRAF V600E Expression and Intratumor BRAF V600E Heterogeneity in Acral Melanoma: Implication in Melanoma-Specific SurvivalTakamichi Ito, Masutaka Furue|Journal of Clinical Medicine|2020Cited by 17
FOXM1: a new therapeutic target of extramammary Paget diseaseTakamichi Ito, Takeshi Nakahara|Scientific Reports|2024Cited by 4